Today: 7 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers (IBKR) Stock This Week: Stablecoin Funding, Global Expansion, and What to Watch Next Week (Updated Dec. 12, 2025)

Interactive Brokers closed Friday at $64.15, down 2.9% after a volatile session that saw shares swing between $66.00 and $62.58. The company began allowing some U.S. retail clients to fund brokerage accounts with stablecoins, enabling direct transfers from crypto wallets. The move comes as investors weigh shifting U.S. rate policy and the firm's global expansion efforts.
13 December 2025
HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Stock Outlook: HCA Healthcare (NYSE: HCA) Ends the Week Near $485 After a Volatile Swing — Latest News, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

HCA Healthcare shares closed at $484.77 on Friday, ending the week nearly unchanged after a sharp 4% drop Wednesday on heavy volume. The midweek decline followed reports of possible Medicare reimbursement cuts under discussion in Congress. HCA remains below its late-November record high of $515.85. Trading volatility this week drew renewed focus to policy risk for hospital operators.
13 December 2025
Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin (LMT) Stock: This Week’s Rally, Fresh F-35 Headlines, and the Week-Ahead Outlook (Updated 12.12.2025)

Lockheed Martin shares closed at $480.25 on Friday, Dec. 12, 2025, capping a nine-session winning streak despite a broader market decline. The stock rose 6.2% over the week. Switzerland announced it will cut its planned F-35 jet purchase to stay within budget, raising questions about future order volumes. Trading volume reached about 1.38 million shares.
Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks Stock Forecast: SBUX News, This Week’s Price Action, and the Week Ahead Updated Dec. 12, 2025

Starbucks shares closed Friday at $85.35, up slightly from last week after rebounding from a Tuesday low of $82.28. The stock remains 28.6% below its 52-week high. A workers’ strike expanded to 34 U.S. cities this week, with over 3,800 employees participating. Starbucks said fewer than 1% of its U.S. stores were affected by the strike.
CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group Inc. Stock (NASDAQ: CME) This Week: Shares Rebound on Strong Volume Data, SEC Clearing-House Greenlight — Week Ahead Outlook (Updated Dec. 12, 2025)

CME Group shares closed at $273.55 on Friday, Dec. 12, up 0.42% for the day and about 1% for the week after rebounding from a midweek low. November average daily volume reached 33.1 million contracts, up 10% year-over-year, marking the company’s second-highest monthly total. The SEC approved CME’s new securities clearing house, set to launch in Q2 2026.
13 December 2025
Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals (VRTX) Stock: This Week’s News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

Vertex Pharmaceuticals shares closed at $452.04 Friday, up 2.26% for the week after rebounding from early losses. The move followed new pediatric data for CASGEVY, showing children ages 5–11 with sickle cell disease remained crisis-free for at least 12 months. Vertex plans global regulatory submissions in 2026. One beta thalassemia patient died from pre-transplant chemotherapy complications.
Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper (SCCO) Stock This Week: Record-High Copper, Analyst Targets, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Southern Copper Corporation closed Friday at $142.41, down 3.54% after shares swung between $141.84 and $149.75. The move tracked copper prices, which neared $12,000/ton this week before retreating. Analyst sentiment remains cautious, with most 12-month targets below the current share price. Southern Copper reported record quarterly results and low cash costs in Q3.
13 December 2025
ConocoPhillips (COP) Stock: This Week’s Moves, Fresh Alaska Lawsuit News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

ConocoPhillips (COP) Stock: This Week’s Moves, Fresh Alaska Lawsuit News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

ConocoPhillips closed at $95.54 on Dec. 12, up 2.86% from Monday, after a volatile week marked by falling oil prices and a new Alaska lawsuit challenging its exploration program. Brent crude settled at $61.12 per barrel, down about 4% for the week. COP remains roughly 10% below its 52-week high of $106.20. Analyst price targets and legal headlines added to trading pressure.
13 December 2025
Chubb (CB) Stock Climbs to a New 52-Week High as AIG Deal Chatter Sparks Volatility — Weekly Recap, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Chubb (CB) Stock Climbs to a New 52-Week High as AIG Deal Chatter Sparks Volatility — Weekly Recap, Forecasts, and the Week Ahead (Updated Dec. 12, 2025)

Chubb Limited shares closed Friday at $308.47, a new 52-week high, after a week of gains driven by M&A speculation involving AIG and positive analyst sentiment. The stock rose 3.8% from Monday’s close, with a brief dip midweek after reports Chubb approached AIG about a takeover—claims both companies denied.
13 December 2025
KKR Stock (NYSE: KKR) Update: This Week’s Rally, Today’s Pullback, Latest News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

KKR Stock (NYSE: KKR) Update: This Week’s Rally, Today’s Pullback, Latest News, Analyst Forecasts, and the Week-Ahead Outlook (Updated Dec. 12, 2025)

KKR shares fell 4.32% to $136.60 on Friday, Dec. 12, ending an eight-day rally and trimming weekly gains to 4.9%. Volume topped 5.3 million shares, above average. The drop followed a surge to $142.77 on Thursday and came as KKR announced a €4.25 billion MasOrange exit deal. The stock remains nearly 20% below its 52-week high.
13 December 2025
Honeywell (HON) Stock Forecast: This Week’s Move, Fresh Company News, and What to Watch Next Week (Updated Dec. 12, 2025)

Honeywell (HON) Stock Forecast: This Week’s Move, Fresh Company News, and What to Watch Next Week (Updated Dec. 12, 2025)

Honeywell shares closed at $193.66 on Dec. 12, down 0.10% as U.S. markets broadly fell. The stock gained 0.9% for the week. Honeywell announced a multi-year building automation partnership with the Charlotte Hornets and won a water infrastructure automation contract in Australia. Indra Nooyi was named to the board, effective January.
13 December 2025
Lowe’s Stock (LOW) This Week: Latest News, Analyst Forecasts, and What Could Move Shares Next Week (Updated Dec. 12, 2025)

Lowe’s Stock (LOW) This Week: Latest News, Analyst Forecasts, and What Could Move Shares Next Week (Updated Dec. 12, 2025)

Lowe’s closed at $247.29 on Friday, Dec. 12, after trading between $240.89 and $251.89 during the week. The company agreed to a $12.5 million settlement with the DOJ and EPA over alleged lead paint rule violations. Investors tracked Lowe’s ongoing push into the Pro and homebuilder market following its recent Foundation Building Materials acquisition.
13 December 2025
UK–Singapore Regulatory Innovation Corridor Launched: MHRA, HSA and Flagship Pioneering Aim to Speed Breakthrough Health Technologies

UK–Singapore Regulatory Innovation Corridor Launched: MHRA, HSA and Flagship Pioneering Aim to Speed Breakthrough Health Technologies

UK and Singapore health regulators have launched a cross-border “Regulatory Innovation Corridor” to speed up access to new medicines and technologies, starting with Flagship Pioneering as the first industry partner. The initiative allows developers to engage both agencies at once for joint advice, aiming to cut duplication and reduce delays in clinical trials and patient access.
13 December 2025
1 577 578 579 580 581 690
Go toTop